CURE Pharmaceutical Holding Corp. (CURR)
| Market Cap | 48.21M |
| Revenue (ttm) | 2.05M |
| Net Income (ttm) | -30.62M |
| Shares Out | 59.52M |
| EPS (ttm) | -0.65 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 16 |
| Last Price | $0.8100 |
| Previous Close | $0.7760 |
| Change ($) | 0.0340 |
| Change (%) | 4.38% |
| Day's Open | 0.7700 |
| Day's Range | 0.7700 - 0.8999 |
| Day's Volume | 98,269 |
| 52-Week Range | 0.7300 - 2.6500 |
OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, reported its financial and operating results for th...
OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it h...
OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it h...
OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it h...
LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a technology focused, vertically integrated drug delivery and product development ...
OXNARD, Calif.--(BUSINESS WIRE)---- $CURR #CBD--CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness pro...
LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)---- $CURR #CBD--According to the National Institute of Health (NIH) more than 50 percent of people worldwide have Vitamin D insufficiency. In response, Sera...
LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)---- $CURR #CBD--The retailers have spoken! Sera Labs, Inc., the wholly owned subsidiary of CURE Pharmaceutical Holdings (OTCQB: CURR), announced today they ...
OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health...
OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp (“CURE” or the “Company”) (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the ...
OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTCQB: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and dru...
OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug ...
OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Closes $10 Million Financing
LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding (OTCQB: CURR) wholly owned subsidiary Sera Labs is challenging the status quo of the health and wellness sector by bringing inn...
OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holdings (OTC: CURR) today announced its definitive agreement to acquire Sera Labs, Inc. The closing is anticipated to occur in early October.
- CURE will present at the LD 500 Virtual Conference, September 4 at 8:20 am PDT -
SHERMAN OAKS, Calif.--(BUSINESS WIRE)-- #Beauty--Sera Labs, a Leader in the CBD Industry to be acquired by CURE Pharmaceutical in a $20 Million Transaction
Significantly higher serum concentration and absorption Showcases CUREform™ encapsulation and oral thin film technology Significantly higher serum concentration and absorption Showcases CUREform™ encaps...
OXNARD, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical, (OTC: CURR), an innovative drug delivery and development company, today announced that its 25,000 square foot manufacturing facil...
- Jonathan Berlent Appointed to Newly Created Role - - Jonathan Berlent Appointed to Newly Created Role -
OXNARD, Calif., June 09, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical Holding Corp. (OTC: CURR), an innovative drug delivery company that is developing novel ways to deliver active ingredients, announ...
About CURR
CURE Pharmaceutical Holding Corp., together with its subsidiaries, operates as an integrated drug delivery and development company in the United States and internationally. It focuses on the development and manufacture of drug formulation and drug delivery technologies in novel dosage forms to enhance drug efficacy, safety, and patient adherence. The company operates through two business segments: Cure and Sera Labs. It offers pharmaceutical and wellness products, including CUREfilm Blue, a sildenafil oral thin film for the treatment of erectil... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | Founded 2011 |
| Stock Exchange OTCMKTS | Ticker Symbol CURR |
Financial Performance
In 2020, CURR's revenue was $2.05 million, an increase of 229.21% compared to the previous year's $623,000. Losses were -$30.62 million, 43.3% more than in 2019.